Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/27605
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWhittaker, Anneen_UK
dc.contributor.authorChandler, Amyen_UK
dc.contributor.authorCunningham-Burley, Sarahen_UK
dc.contributor.authorMidgley, Paulaen_UK
dc.contributor.authorElliott, Lawrieen_UK
dc.contributor.authorCooper, Sarahen_UK
dc.date.accessioned2018-08-04T00:02:01Z-
dc.date.available2018-08-04T00:02:01Z-
dc.date.issued2019-06en_UK
dc.identifier.urihttp://hdl.handle.net/1893/27605-
dc.description.abstractBackground Neonatal Abstinence Syndrome (NAS) is an anticipated effect of maternal drug use during pregnancy. Yet it remains a contested area of policy and practice. In this paper, we contribute to ongoing debates about the way NAS is understood and responded to, through different treatment regimes, or logics of care. Our analysis examines the role of risk and recovery discourses, and the way in which the bodies of women and babies are conceptualised within these. Methods Qualitative interviews with 16 parents (9 mothers, 7 fathers) and four focus groups with 27 health and social care professionals based in Scotland. All the mothers were prescribed opioid replacement therapy and parents were interviewed after their baby was born. Data collection explored understandings about the causes and consequences of NAS and experiences of preparing for, and caring for, a baby with NAS. Data were analysed using a narrative and discursive approach. Results Parent and professional accounts simultaneously upheld and subverted logics of care which govern maternal drug use and the assessment and care of mother and baby. Despite acknowledging the unpredictability of NAS symptoms and the inability of the women who are opioid-dependent to prevent NAS, logics of care centred on ‘proving’ risk and recovery. Strategies appealed to the need for caution, intervening and control, and obscured alternative logics of care that focus on improving support for mother-infant dyads and the family as a whole. Conclusion Differing notions of risk and recovery that govern maternal drug use, child welfare and family life both compel and trouble all logics of care. The contentious nature of NAS reflects wider socio-political and moral agendas that ultimately have little to do with meeting the needs of mothers and babies. Fundamental changes in the principles, quality and delivery of care could improve outcomes for families affected by NAS.en_UK
dc.language.isoenen_UK
dc.publisherElsevieren_UK
dc.relationWhittaker A, Chandler A, Cunningham-Burley S, Midgley P, Elliott L & Cooper S (2019) Problematisation and regulation: Bodies, risk, and recovery within the context of Neonatal Abstinence Syndrome. International Journal on Drug Policy, 68, pp. 139-146. https://doi.org/10.1016/j.drugpo.2018.06.006en_UK
dc.rightsThis item has been embargoed for a period. During the embargo please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author. You can only request a copy if you wish to use this work for your own research or private study. Accepted refereed manuscript of: Whittaker A, Chandler A, Cunningham-Burley S, Midgley P, Elliott L & Cooper S (2019) Problematisation and regulation: Bodies, risk, and recovery within the context of Neonatal Abstinence Syndrome. International Journal on Drug Policy, 68, pp. 139-146. DOI: https://doi.org/10.1016/j.drugpo.2018.06.006. © 2019, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/en_UK
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en_UK
dc.subjectNeonatal Abstinence Syndromeen_UK
dc.subjectPregnancyen_UK
dc.subjectOpioid dependenceen_UK
dc.subjectRisken_UK
dc.subjectRecoveryen_UK
dc.subjectQualitativeen_UK
dc.titleProblematisation and regulation: Bodies, risk, and recovery within the context of Neonatal Abstinence Syndromeen_UK
dc.typeJournal Articleen_UK
dc.rights.embargodate2019-07-18en_UK
dc.rights.embargoreason[DRUGPO-D-18-51R1-ACCEPTED.pdf] Publisher requires embargo of 12 months after formal publication.en_UK
dc.identifier.doi10.1016/j.drugpo.2018.06.006en_UK
dc.identifier.pmid30025899en_UK
dc.citation.jtitleInternational Journal of Drug Policyen_UK
dc.citation.issn0955-3959en_UK
dc.citation.volume68en_UK
dc.citation.spage139en_UK
dc.citation.epage146en_UK
dc.citation.publicationstatusPublisheden_UK
dc.citation.peerreviewedRefereeden_UK
dc.type.statusAM - Accepted Manuscripten_UK
dc.contributor.funderEdinburgh and Lothians Health Foundationen_UK
dc.author.emailanne.whittaker@stir.ac.uken_UK
dc.citation.date17/07/2018en_UK
dc.contributor.affiliationNMAHPen_UK
dc.contributor.affiliationUniversity of Edinburghen_UK
dc.contributor.affiliationUniversity of Edinburghen_UK
dc.contributor.affiliationUniversity of Edinburghen_UK
dc.contributor.affiliationGlasgow Caledonian Universityen_UK
dc.contributor.affiliationNHS Lothianen_UK
dc.identifier.isiWOS:000471733700019en_UK
dc.identifier.scopusid2-s2.0-85049925352en_UK
dc.identifier.wtid963641en_UK
dc.contributor.orcid0000-0001-8960-5070en_UK
dc.date.accepted2018-06-11en_UK
dcterms.dateAccepted2018-06-11en_UK
dc.date.filedepositdate2018-08-03en_UK
rioxxterms.apcnot requireden_UK
rioxxterms.typeJournal Article/Reviewen_UK
rioxxterms.versionAMen_UK
local.rioxx.authorWhittaker, Anne|0000-0001-8960-5070en_UK
local.rioxx.authorChandler, Amy|en_UK
local.rioxx.authorCunningham-Burley, Sarah|en_UK
local.rioxx.authorMidgley, Paula|en_UK
local.rioxx.authorElliott, Lawrie|en_UK
local.rioxx.authorCooper, Sarah|en_UK
local.rioxx.projectProject ID unknown|Edinburgh and Lothians Health Foundation|http://dx.doi.org/10.13039/100010898en_UK
local.rioxx.freetoreaddate2019-07-18en_UK
local.rioxx.licencehttp://www.rioxx.net/licenses/under-embargo-all-rights-reserved||2019-07-17en_UK
local.rioxx.licencehttp://creativecommons.org/licenses/by-nc-nd/4.0/|2019-07-18|en_UK
local.rioxx.filenameDRUGPO-D-18-51R1-ACCEPTED.pdfen_UK
local.rioxx.filecount1en_UK
local.rioxx.source0955-3959en_UK
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles

Files in This Item:
File Description SizeFormat 
DRUGPO-D-18-51R1-ACCEPTED.pdfFulltext - Accepted Version1.2 MBAdobe PDFView/Open


This item is protected by original copyright



A file in this item is licensed under a Creative Commons License Creative Commons

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.